Harm/ risk (analysis)

Latest Articles

Article
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.

Neurology September 12, 2019
Editorial
Dosing interval of natalizumab in MSDo good things come to those who wait?
David B. Clifford, Kenneth L. Tyler

Neurology September 12, 2019
Article
Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA
Caty Carrera, Natalia Cullell, Nuria Torres-Águila, et al.

Neurology July 31, 2019
Article
High-dose methylprednisolone for acute traumatic spinal cord injuryA meta-analysis
Zhongyu Liu, Yang Yang, Lei He, et al.

Neurology July 29, 2019

Advertisement

NMO Treatment Strategy; Prodromal Parkinson’s Disease

Dr. Ted Burns talks with Dr. Stacey Clardy about prevention and treatment of neuromyelitis optica

December 3, 2019 Issue

Neurology, Journal, podcast

Listen24:16

Disclosures

View Recent Podcasts